Apoptosis

There are many forms of cell death, most of which can be triggered by a variety of stimuli and physiological conditions. The often compared are apoptosis and necrosis. Apoptosis has become the focus of research area due to its complex nature and the different roles of maintaining healthy and self-sustaining biological entities. On the other hand, necrosis is a form of cell damage against acute external injury and trauma, leading to passive cell death and causing an inflammatory response. [1]

The BCl-2 family has been identified as its important role in apoptosis. The BH domain promotes interaction of family members with one another and may be indicative of pro-apoptotic or anti-apoptotic functions. Usually the BCL-2 family have been classified into one of three subfamilies; anti-apoptosis,  BH3 only (pro-apoptotic) and pro-apoptotic proteins. The great promise for cancer therapy has been shown in recent research about BCL-2 targeting.[2]

In the cell cycle, apoptosis acts as a fail-safe measure to prevent fidelity and proliferation quality. Although a certain degree of genetic variation is allowed and evolution is promoted, regenerative cells with extensive genetic errors and cell damage are subject to apoptosis. P53 is the Key role in the cell cycle system which  initiate the apoptosis in certain cell types. P53 is a widely studied tumor suppressor. The p53 tumor suppressor gene is most frequently mutated in cancer cells (mutation occurs in more than 50% of human cancers) [3], which makes the restriction mechanism ineffective. Tumorigenesis is likely to commence when the p53-based preventive system loses its function completely.

Expression of stimuli, such as DNA damage, hypoxia and activation of certain oncoproteins (eg, Myc, Ras) are dependent on the apoptotic pathway of p53 [4]. The transactivation function of p53 plays an important role in inducing apoptosis, the pro-apoptotic proteins, Bax and lgF-Bp3, are transcriptional targets of p53.[5] As a well-known tumor suppressor, p53 is recognized for its ability to initiate apoptosis in the cell cycle and its ability to induce cell arrest and DNA repair in regenerative cells. In addition to p53, there are many other cell cycle regulators that can affect apoptosis (eg, pRb, p21).

Many studies have emphasized the importance of apoptosis in the self-defense mechanism or immune system. The immune system is responsible for rendering the host resistant to a variety of external pathogens. Apoptosis is an integral part of the immune system and helps maintain the homeostasis of the immune system.  Secondly, the immune system relies on apoptosis to eliminate unwanted functional maturation of T cells and B cells [6].  Finally, apoptosis confers cytotoxicity to certain cell types (ie, cytotoxic T lymphocytes and natural killer cells). A well-coordinated disruption protocol allows these cells to destroy target cells while the target cells remain intact. Cytotoxic T lymphocytes (CTLs) can induce target cell death in two ways, one of which involves perforin and granzymes.

  • Majno G. and Joris I. (1995) Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol. 146, 3–15
  • Zhiqing Liu, et al. Drug Discov Today. 2016 Jun; 21(6): 989–996.
  • Wang X.W. and Harris C.C. (1997) p53 tumor-suppressor gene: clues to molecular carcinogenesis. J. Cell. Physiol. 173, 247–255 10.1002/(SICI)1097-4652(199711)173:2%3c247::AID-JCP30%3e3.0.CO;2-A.
  • Levine A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323–331 10.1016/S0092-8674(00)81871-1.
  • Owen-Schaub LB,et al. Owen-Schaub LB,Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol. 1995 Jun; 15(6):3032-40.
  • Russell J.H. (1995) Activation-induced death of mature T cells in the regulation of immune responses. Curr. Opin. Immunol. 7, 382–388 10.1016/0952-7915(95)80114-6.

产品 101 到 150 共 198个

每页
页面:
  1. 1
  2. 2
  3. 3
  4. 4

设置升序顺序
  1. RG7112

    Catalog No. A11523
    Quick View
    selective p53-MDM2 抑制剂
    RG7112是首个临床小分子MDM2抑制剂,HTRF IC50为18 nM,设计用于占据MDM2的p53结合口袋。 了解更多
  2. PK11007

    Catalog No. A16833
    Quick View
    p53 activator
    PK11007是一种抗p53药物,可通过两个表面暴露的半胱氨酸的选择性烷基化来稳定野生型和突变型p53,而不会损害其DNA结合活性。它不仅通过重新激活p53发挥抗肿瘤功能,还通过其他细胞机制发挥作用,例如将细胞ROS升高至毒性水平并激活UPR。 了解更多
  3. CBL-0137

    Catalog No. A16836
    Quick View
    p53 activator / NF-κB 抑制剂
    CBL0137 (CBL-0137)在基于细胞的p53和NF-kB报告基因检测中分别激活p53和抑制NF-kB,EC50为0.37 uM和0.47 uM。它还抑制组蛋白伴侣FACT(促进染色质转录复合物)。 了解更多
  4. Pifithrin-β

    Catalog No. A22006
    Quick View
    p53 inhibitor
    Pifithrin-β (PFT β) is a potent p53 inhibitor with an IC50 of 23 μM. 了解更多
  5. Lenalidomide (CC-5013)

    Catalog No. A10522
    Quick View
    Ubiquitin ligase inducer
    Lenalidomide (CC-5013)是Thalidomide的衍生物。在体外,Lenalidomide具有三种主要活性:直接抗肿瘤作用、抑制肿瘤细胞的微环境支持和免疫调节作用。它通过抑制骨髓基质细胞支持、抗血管生成和抗破骨细胞生成作用以及免疫调节活性直接和间接诱导肿瘤细胞凋亡。 了解更多
  6. QNZ (EVP4593)

    Catalog No. A12748
    Quick View
    NF-κB 抑制剂
    QNZ抑制转录因子NF-κB的激活,已被用于研究NF-κB信号传导。 了解更多
  7. Pomalidomide (CC-4047)

    Catalog No. A10743
    Quick View
    TNF-alpha 抑制剂
    Pomalidomide (CC-4047)是沙利度胺的衍生物,在PBMCs中IC50为13 nM,并起免疫调节剂的作用。 了解更多
  8. Necrostatin-1

    Catalog No. A11973
    Quick View
    RIPK1 抑制剂
    Necrostatin-1是一种与ATP竞争的,与受体相互作用的蛋白激酶1(RIPK1)的变构抑制剂(EC50 = 182 nM)。 了解更多
  9. GW 4869

    Catalog No. A11974
    Quick View
    N-SMase 抑制剂
    W4869是N-SMase(中性鞘磷脂酶)的细胞渗透性选择性抑制剂。 了解更多
  10. Necrostatin 2

    Catalog No. A15183
    Quick View
    Necroptosis 抑制剂
    Necrostatin 2 是一种有效的坏死性抑制剂,EC50为50 nM。 了解更多
  11. Necrostatin 2 racemate

    Catalog No. A15327
    Quick View
    Necroptosis 抑制剂
    Necrostatin 2 racemate是一种有效的坏死性抑制剂,EC50为50 nM。 了解更多
  12. Necrostatin 2 S enantiomer

    Catalog No. A15328
    Quick View
    Necroptosis 抑制剂
    Necrostatin 2 S enantiomer是一种有效的坏死性抑制剂,EC50为50 nM。 了解更多
  13. Thalidomide

    Catalog No. A10924
    Quick View
    E3 ubiquitin ligase 抑制剂
    Thalidomide可以在体内直接抑制bFGF或VEGF诱导的血管生成。 了解更多
  14. C 87

    Catalog No. A12313
    Quick View
    TNFα inhibitor
    C87 is a novel small-molecule TNFα inhibitor; potently inhibits TNFα-induced cytotoxicity with an IC50 of 8.73 μM. 了解更多
  15. LCL-161

    Catalog No. A11928
    Quick View
    拮抗剂of IAPs抑制剂
    LCL161是口服生物可利用的第二个线粒体衍生的半胱天冬酶(SMAC)类似物激活剂,也是IAP(细胞凋亡抑制蛋白)家族蛋白的抑制剂,具有潜在的抗肿瘤活性,抑制 HEK293 细胞中 XIAP 和 MDA-MB-231细胞中 cIAP1 的 IC50分别为 35 和 0.4 nM。 了解更多
  16. AT-406 (SM-406, ARRY-334543)

    Catalog No. A11163
    Quick View
    IAP 抑制剂
    AT-406 (SM-406,ARRY-334543)是IAP家族蛋白质的口服生物利用抑制剂,具有潜在的凋亡诱导和抗肿瘤活性。AT-406选择性抑制IAP蛋白的生物学活性,包括X染色体连锁IAP(XIAP),细胞IAP 1(c-IAP1)和2(c-IAP2)和黑色素瘤凋亡抑制蛋白(ML-IAP)。 了解更多
  17. BV-6

    Catalog No. A14231
    Quick View
    dual cIAP and XIAP 抑制剂
    BV-6是一种SMAC模拟,双重cIAP和XIAP抑制剂。 了解更多
  18. SM-164

    Catalog No. A15800
    Quick View
    cIAP-2 拮抗剂
    SM-164是一种有效的细胞渗透性二价Smac模拟物,它与KiAP为0.56 nM的XIAP蛋白结合,并分别与Ki值为0.31和1.1 nM的cIAP-1和cIAP-2蛋白结合。 了解更多
  19. Birinapant (TL32711)

    Catalog No. A12738
    Quick View
    XIAP/cIAP1 拮抗剂
    Birinapant (TL32711)是第二个线粒体衍生的胱天蛋白酶(SMAC)激活剂和IAP(凋亡蛋白抑制剂)家族蛋白抑制剂的合成小分子和肽类似物,对cIAP1最有效,无细胞试验中Kd为<1 nM,具有潜在的抗肿瘤活性。 了解更多
  20. GDC-0152

    Catalog No. A14135
    Quick View
    IAP 拮抗剂
    GDC-0152是caspases(Smac)的第二个线粒体激活物,具有潜在的抗肿瘤活性。 了解更多
  21. Embelin

    Catalog No. A13055
    Quick View
    XIAP 抑制剂
    Embelin是一种细胞可渗透的苯醌化合物,具有抗肿瘤特性。 了解更多
  22. Apoptosis Inhibitor (M50054)

    Catalog No. A13058
    Quick View
    Apoptosis 抑制剂
    Apoptosis Inhibitor (M50054)是细胞可渗透的凋亡诱导抑制剂。 了解更多
  23. Nutlin-3

    Catalog No. A10657
    Quick View
    Mdm2 拮抗剂
    Nutlin-3是一种有效的,选择性Mdm2(它自身和p53的环指依赖性泛素蛋白连接酶)拮抗剂,是有效的凋亡诱导剂。 了解更多
  24. Nutlin 3a

    Catalog No. A11501
    Quick View
    MDM2 抑制剂
    Nutlin 3a是与p53结合的MDM2(小鼠双分钟2)有效抑制剂,可诱导p53调控基因的表达,并在表达功能性p53的细胞中表现出有效的抗增殖活性。 了解更多
  25. NSC-207895 (XI-006)

    Catalog No. A11179
    Quick View
    MDMX 抑制剂
    NSC-207895 (XI-006)是细胞可渗透的苯并呋喃化合物,可通过抑制MDMX启动子转录活性(IC50 = 2.5 ?M,下调MCF-7,LNCaP和A549细胞中的p53负调节剂MDMX蛋白水平(1至10 ?M,持续16至24 h)),导致增强的p53稳定和激活。 了解更多
  26. Nutlin 3b

    Catalog No. A11502
    Quick View
    MDM2 抑制剂
    Nutlin 3b是p53/MDM2拮抗剂或抑制剂,IC50值为13.6 uM,与相反的(-)-对映体Nutlin-3a相比,Nutlin-3的有效(+)-对映体少150倍。 了解更多
  27. Idasanutlin (RG7388)

    Catalog No. A14211
    Quick View
    MDM2/p53 抑制剂
    Idasanutlin (RG7388)是一种有效的选择性p53-MDM2抑制剂。 了解更多
  28. YH239-EE

    Catalog No. A14118
    Quick View
    Mdm2 抑制剂
    YH239-EE是有效的p53-MDM2拮抗剂和凋亡诱导剂。 了解更多
  29. AMG232

    Catalog No. A14394
    MDM2 抑制剂
    AMG 232是MDM2-p53相互作用的高效,选择性生物利用的哌啶酮抑制剂(SPR KD = 0.045 nM,SJSA-1 EdU IC50 = 9.1 nM)。 了解更多
  30. MI-773

    Catalog No. A15440
    Quick View
    MDM2 抑制剂
    MI-773是可用的MDM2拮抗剂,Ki为0.88 nM。 了解更多
  31. (4R,5S)-nutlin carboxylic acid

    Catalog No. A18924
    Quick View
    Nutlin 3-based MDM2 ligand
    (4R,5S)-nutlin carboxylic acid (MDM2 ligand 2) is the Nutlin 3-based MDM2 ligand. (4R,5S)-nutlin carboxylic acid can be connected to the ligand for protein by a linker to form PROTACs. 了解更多
  32. Nutlin carboxylic acid

    Catalog No. A18917
    Quick View
    Nutlin 3-based MDM2 ligand
    Nutlin carboxylic acid (MDM2 ligand 1) is the Nutlin 3-based MDM2 ligand. Nutlin carboxylic acid (MDM2 ligand 1) can be connected to the ligand for protein by a linker to form PROTACs. 了解更多
  33. PROTAC MDM2 Degrader-1

    Catalog No. A18897
    Quick View
    MDM2 degrader
    PROTAC MDM2 Degrader-1 is a MDM2 degrader based on PROTAC technology. PROTAC MDM2 Degrader-1 composes of a potent MDM2 inhibitor, linker, and the MDM2 ligand for E3 ubiquitin ligase. 了解更多
  34. PROTAC MDM2 Degrader-2

    Catalog No. A18890
    Quick View
    MDM2 inhibitor
    PROTAC MDM2 Degrader-2 is a MDM2 degrader based on PROTAC technology. PROTAC MDM2 Degrader-2 composes of a potent MDM2 inhibitor, linker, and the MDM2 ligand for E3 ubiquitin ligase. 了解更多
  35. PROTAC MDM2 Degrader-3

    Catalog No. A18883
    Quick View
    MDM2 degrader
    PROTAC MDM2 Degrader-3 is a MDM2 degrader based on PROTAC technology. PROTAC MDM2 Degrader-3 composes of a potent MDM2 inhibitor, linker, and the MDM2 ligand for E3 ubiquitin ligase. 了解更多
  36. PROTAC MDM2 Degrader-4

    Catalog No. A18877
    Quick View
    MDM2 inhibitor
    PROTAC MDM2 Degrader-4 is a MDM2 degrader based on PROTAC technology. PROTAC MDM2 Degrader-4 composes of a potent MDM2 inhibitor, linker, and the MDM2 ligand for E3 ubiquitin ligase. 了解更多
  37. MA242

    Catalog No. A13480
    Quick View
    dual MDM2/NFAT1 inhibitor
    MA242 is a dual inhibitor of murine double minute 2 (MDM2) and nuclear factor of activated T cells 1 (NFAT1) for Pancreatic Cancer Therapy. 了解更多
  38. APG-115

    Catalog No. A12575
    Quick View
    MDM2 inhibitor
    APG-115 (AA-115) is an orally active MDM2 protein inhibitor binding to MDM2 protein with IC50 and Ki values of 3.8 nM and 1 nM, respectively. 了解更多
  39. RO8994

    Catalog No. A20865
    Quick View
    MDM2 inhibitor
    RO8994 is a highly potent and selective series of spiroindolinone small-molecule MDM2 inhibitor, with IC50 of 5 nM (HTRF binding assays) and 20 nM (MTT proliferation assays). 了解更多
  40. MDM2 Inhibitor

    Catalog No. A13582
    Quick View
    MDM2 抑制剂
    MDM2 Inhibitor是一种细胞可渗透的硼烷基查尔酮,表现出与MDM2的强结合,并不可逆地破坏MDM2/p53蛋白复合物。 了解更多
  41. WK23

    Catalog No. A14051
    Quick View
    MDM2/MDMX 抑制剂
    WK23是基于四个芳香族基团的抑制剂,能够有效填充MDM2/MDMX的结合口袋,其对MDM2/MDMX的中位抑制浓度(IC50)值分别为1.17和36 uM。 了解更多
  42. MI-773 (SAR405838)

    Catalog No. A14423
    Quick View
    Mdm2 抑制剂
    MI-773 (SAR405838)是一种新的MDM2-p53相互作用的小分子抑制剂,以高亲和力(Ki = 0.88 nM)结合MDM2,并阻断p53-MDM2相互作用。 了解更多
  43. NVP-CGM097

    Catalog No. A16326
    Quick View
    MDM2 抑制剂
    NVP-CGM097是一种有效的选择性MDM2抑制剂。具有潜在抗肿瘤活性的口服生物利用型HDM2拮抗剂。 了解更多
  44. MX-69

    Catalog No. A16348
    Quick View
    MDM2/XIAP 抑制剂
    MX-69是MDM2/XIAP抑制剂,用于癌症治疗。 了解更多
  45. HDM201

    Catalog No. A16834
    Quick View
    MDM2 抑制剂
    HDM201是新型,高效且选择性的p53-Mdm2相互作用抑制剂,其对Mdm2的亲和常数在皮摩尔范围内,相对Mdm4的选择性比大于10000倍。 了解更多
  46. RO-5963

    Catalog No. A18813
    Quick View
    MDM2/MDMX inhibitor
    RO-5963 is an inhibitor of the interaction of both MDM2 and MDMX with p53 with IC50s of ~17 nM and ~24 nM, respectively. 了解更多
    • 最新产品

    MD-224

    Catalog No. A18712
    Quick View
    MDM2 degrader
    MD-224 is a first-in-class and highly potent small-molecule human murine double minute 2 (MDM2) degrader based on the proteolysistargeting chimera (PROTAC) concept. MD-224 has the potential to be a new class of anticancer agent. 了解更多
  47. MI-1061

    Catalog No. A18450
    Quick View
    MDM2 inhibitor
    MI-1061 is a potent, orally bioavailable, and chemically stable MDM2 (MDM2-p53 interaction) inhibitor (IC50=4.4 nM; Ki=0.16 nM). MI-1061 potently activates p53, induces apoptosis, and has anti-tumor activity. 了解更多
  48. Homoharringtonine

    Catalog No. A14490
    Quick View
    Stat3 抑制剂 & Apoptosis inducer
    同型harringtonine是一种头孢他辛生物碱,可抑制肝核糖体中二苯丙氨酸和乙酰苯丙氨酰嘌呤霉素的形成。 了解更多
  49. Difopein

    Catalog No. A14917
    14-3-3 protein 抑制剂
    Difopein,R18肽的二聚体形式,以高亲和力与14.3.3蛋白结合。 了解更多

产品 101 到 150 共 198个

每页
页面:
  1. 1
  2. 2
  3. 3
  4. 4

设置升序顺序
Rewards